Your browser doesn't support javascript.
loading
The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai, Minxian; Freeman, Brandi; Bruno, Fernando P; Shikani, Henry J; Tanowitz, Herbert B; Weiss, Louis M; Reznik, Sandra E; Stephani, Ralph A; Desruisseaux, Mahalia S.
Affiliation
  • Dai M; Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, United States.
Life Sci ; 91(13-14): 687-92, 2012 Oct 15.
Article in En | MEDLINE | ID: mdl-22820174
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebral Hemorrhage / Malaria, Cerebral / Artemisinins / Endothelin A Receptor Antagonists / Hydroxyquinolines Limits: Animals Language: En Journal: Life Sci Year: 2012 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebral Hemorrhage / Malaria, Cerebral / Artemisinins / Endothelin A Receptor Antagonists / Hydroxyquinolines Limits: Animals Language: En Journal: Life Sci Year: 2012 Document type: Article Affiliation country: Country of publication: